Clinical study of liver cancer
Not Applicable
- Conditions
- Health Condition 1: C220- Liver cell carcinoma
- Registration Number
- CTRI/2023/02/049609
- Lead Sponsor
- Kasturba Medical College, Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed hepatocellular carcinoma cases and already diagnosed cases on follow up
Exclusion Criteria
Age less than 18 years
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the clinical profile of Hepatocellular Carcinoma using history, examination, lab parameters and radiological investigations. Barcelona Clinic Liver Cancer <br/ ><br>Staging System (BCLC) will be used to assess the severity at presentation. <br/ ><br>Timepoint: Newly diagnosed Hepatocellular carcinoma patients and already diagnosed cases on follow up to Kasturba Hospital, Manipal during the period of study of 1 year and 6 months.
- Secondary Outcome Measures
Name Time Method Knowing the clinical profile of the patient and correlating it to the severity of hepatocellular carcinoma at presentation can help predict the course of the disease and thus help adopt appropriate treatment course to reduce the morbidity and mortality.Timepoint: Newly diagnosed Hepatocellular carcinoma patients and already diagnosed cases on follow up to Kasturba Hospital, Manipal during the period of study of 1 year and 6 months.